Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
47 "Thyroid hormone"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Article
Triiodothyronine Is Associated with Incidence/Resolution of Steatotic Liver Disease: Longitudinal Study in Euthyroid Korean
Hye In Kim, Jun Young Kim, Jung Hwan Cho, Ji Min Han, Sunghwan Suh, Ji Cheol Bae, Tae Hyuk Kim, Sun Wook Kim, Jong Ryeal Hahm, Jae Hoon Chung
Received May 11, 2024  Accepted July 19, 2024  Published online December 4, 2024  
DOI: https://doi.org/10.3803/EnM.2024.2040    [Epub ahead of print]
  • 159 View
  • 10 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The positive relationship between triiodothyronine (T3) and steatotic liver disease (SLD) demonstrated only in crosssectional study. We aimed to evaluated whether total T3 (TT3) is associated with the development/resolution of SLD in longitudinal design.
Methods
This retrospective, longitudinal, population-based cohort study included 1,665 South Korean euthyroid adults with ≥4 thyroid function test. We explored the impact of mean TT3 during follow-up on development/resolution of either SLD (diagnosed by ultrasound) or modified metabolic dysfunction-associated steatotic liver disease (MASLD) using Cox proportional hazards regression models.
Results
During about median 5 years follow-up, 807/1,216 (66.3%) participants among participants without SLD at baseline developed SLD, and 253/318 (79.5%) participants among participants with SLD at baseline SLD resolved fatty liver. Mean TT3 rather than thyroid stimulating hormone or mean free thyroxine was significantly related with development (adjusted hazard ratio [HR], 1.01; 95% confidence interval [CI], 1.00 to 1.02; P=0.002) and resolution (adjusted HR, 0.97; 95% CI, 0.96 to 0.99; P=0.005) of SLD. Compared with low mean TT3 group, high mean TT3 group was positively associated with development of SLD (adjusted HR,1.20; 95% CI, 1.05 to 1.38; P=0.008) and inversely associated with resolution of SLD (adjusted HR, 0.66; 95% CI, 0.51 to 0.85; P=0.001). The statistical significance remained for development (adjusted HR, 1.29; 95% CI, 1.10 to 1.51; P=0.001) and resolution (adjusted HR, 0.71; 95% CI, 0.54 to 0.94; P=0.018) of modified MASLD.
Conclusion
In Korean euthyroid adults, TT3 level was associated with development and resolution of either SLD or modified MASLD.
Close layer
Review Articles
Thyroid
Thyroid Hormone-Mediated Selective Autophagy and Its Implications in Countering Metabolic Dysfunction-Associated Steatotic Liver Disease
Rohit A. Sinha
Endocrinol Metab. 2024;39(5):686-692.   Published online October 14, 2024
DOI: https://doi.org/10.3803/EnM.2024.2068
  • 807 View
  • 61 Download
AbstractAbstract PDFPubReader   ePub   
The influence of thyroid hormone (TH) on liver metabolism has attracted the attention of pharmacologists seeking new treatments for metabolic dysfunction-associated steatotic liver disease (MASLD), an increasingly common metabolic disorder. In this context, the selective induction of autophagy by TH in preclinical models has been identified as a promising mechanism. In this process, TH clears intrahepatic fat through lipophagy while protecting against inflammation and mitochondrial damage in hepatocytes via mitophagy. Furthermore, TH-induced aggrephagy may represent a protective mechanism to mitigate the development of MASLD-associated hepatocellular carcinoma. Considering the defects in autophagy observed during the progression of human MASLD, the induction of autophagy by TH, its metabolites, and its analogs represent a novel strategy to combat hepatic damage across the MASLD spectrum.
Close layer
Calcium & bone metabolism
Roles of Parathyroid Hormone and Fibroblast Growth Factor 23 in Advanced Chronic Kidney Disease
Yosuke Nakagawa, Hirotaka Komaba
Endocrinol Metab. 2024;39(3):407-415.   Published online May 16, 2024
DOI: https://doi.org/10.3803/EnM.2024.1978
  • 3,332 View
  • 171 Download
AbstractAbstract PDFPubReader   ePub   
Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) each play a central role in the pathogenesis of chronic kidney disease (CKD)-mineral and bone disorder. Levels of both hormones increase progressively in advanced CKD and can lead to damage in multiple organs. Secondary hyperparathyroidism (SHPT), characterized by parathyroid hyperplasia with increased PTH secretion, is associated with fractures and mortality. Emerging evidence suggests that these associations may be partially explained by PTH-induced browning of adipose tissue and increased energy expenditure. Observational studies suggest a survival benefit of PTHlowering therapy, and a recent study comparing parathyroidectomy and calcimimetics further suggests the importance of intensive PTH control. The mechanisms underlying the regulation of FGF23 secretion by osteocytes in response to phosphate load have been unclear, but recent experimental studies have identified glycerol-3-phosphate, a byproduct of glycolysis released by the kidney, as a key regulator of FGF23 production. Elevated FGF23 levels have been shown to be associated with mortality, and experimental data suggest off-target adverse effects of FGF23. However, the causal role of FGF23 in adverse outcomes in CKD patients remains to be established. Further studies are needed to determine whether intensive SHPT control improves clinical outcomes and whether treatment targeting FGF23 can improve patient outcomes.
Close layer
Calcium & bone metabolism
Treatment of Hypoparathyroidism by Re-Establishing the Effects of Parathyroid Hormone
Lars Rejnmark
Endocrinol Metab. 2024;39(2):262-266.   Published online April 4, 2024
DOI: https://doi.org/10.3803/EnM.2024.1916
  • 7,229 View
  • 391 Download
  • 3 Web of Science
  • 2 Crossref
AbstractAbstract PDFPubReader   ePub   
The conventional treatment of hypoparathyroidism (HypoPT) includes active vitamin D and calcium. Despite normalization of calcium levels, the conventional treatment is associated with fluctuations in calcium levels, hypercalciuria, renal impairment, and decreased quality of life (QoL). Replacement therapy with parathyroid hormone (PTH)(1-84) is an option in some countries. However, convincing beneficial effects have not been demonstrated, which may be due to the short duration of action of this treatment. Recently, palopegteriparatide (also known as TransCon PTH) has been marketed in Europe and is expected also to be approved in other countries. Palopegteriparatide is a prodrug with sustained release of PTH(1-34) designed to provide stable physiological PTH levels for 24 hours/day. A phase 3 study demonstrated maintenance of normocalcemia in patients with chronic HypoPT, with no need for conventional therapy. Furthermore, this treatment lowers urinary calcium and improves QoL. Another long-acting PTH analog with effects on the parathyroid hormone receptor (eneboparatide) is currently being tested in a phase 3 trial. Furthermore, the treatment of autosomal dominant hypocalcemia type 1 with a calcilytic (encaleret) is also being tested. All in all, improved treatment options are on the way that will likely take the treatment of HypoPT to the next level.

Citations

Citations to this article as recorded by  
  • Hypoparathyroidism update
    Cherie Chiang
    Current Opinion in Endocrinology, Diabetes & Obesity.2024;[Epub]     CrossRef
  • Potential of Calcilytics as a Novel Treatment for Post-Surgical Hypoparathyroidism
    Han Seok Choi
    Endocrinology and Metabolism.2024; 39(3): 534.     CrossRef
Close layer
Original Articles
Calcium & bone metabolism
Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality
Sung Hye Kong, Jeong Mo Bae, Jung Hee Kim, Sang Wan Kim, Dohyun Han, Chan Soo Shin
Endocrinol Metab. 2024;39(2):375-386.   Published online March 21, 2024
DOI: https://doi.org/10.3803/EnM.2023.1827
  • 2,265 View
  • 53 Download
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Parathyroid adenoma (PA) is a common endocrine disease linked to multiple complications, but the pathophysiology of the disease remains incompletely understood. The study aimed to identify the key regulator proteins and pathways of PA according to functionality and volume through quantitative proteomic analyses.
Methods
We conducted a retrospective study of 15 formalin-fixed, paraffin-embedded PA samples from tertiary hospitals in South Korea. Proteins were extracted, digested, and the resulting peptides were analyzed using liquid chromatography-tandem mass spectrometry. Pearson correlation analysis was employed to identify proteins significantly correlated with clinical variables. Canonical pathways and transcription factors were analyzed using Ingenuity Pathway Analysis.
Results
The median age of the participants was 52 years, and 60.0% were female. Among the 8,153 protein groups analyzed, 496 showed significant positive correlations with adenoma volume, while 431 proteins were significantly correlated with parathyroid hormone (PTH) levels. The proteins SLC12A9, LGALS3, and CARM1 were positively correlated with adenoma volume, while HSP90AB2P, HLA-DRA, and SCD5 showed negative correlations. DCPS, IRF2BPL, and FAM98A were the main proteins that exhibited positive correlations with PTH levels, and SLITRK4, LAP3, and AP4E1 had negative correlations. Canonical pathway analysis demonstrated that the RAN and sirtuin signaling pathways were positively correlated with both PTH levels and adenoma volume, while epithelial adherence junction pathways had negative correlations.
Conclusion
Our study identified pivotal proteins and pathways associated with PA, offering potential therapeutic targets. These findings accentuate the importance of proteomics in understanding disease pathophysiology and the need for further research.
Close layer
Thyroid
Big Data Articles (National Health Insurance Service Database)
Risk of Subsequent Primary Cancers in Thyroid Cancer Survivors according to the Dose of Levothyroxine: A Nationwide Cohort Study
Min-Su Kim, Jang Won Lee, Min Kyung Hyun, Young Shin Song
Endocrinol Metab. 2024;39(2):288-299.   Published online March 4, 2024
DOI: https://doi.org/10.3803/EnM.2023.1815
  • 4,146 View
  • 149 Download
  • 1 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Current research has not investigated the effect of thyroid-stimulating hormone suppression therapy with levothyroxine on the risk for developing subsequent primary cancers (SPCs). This study aimed to investigate the association between levothyroxine dosage and the risk for SPCs in thyroid cancer patients.
Methods
We conducted a nationwide population-based retrospective cohort study form Korean National Health Insurance database. This cohort included 342,920 thyroid cancer patients between 2004 and 2018. Patients were divided into the non-levothyroxine and the levothyroxine groups, the latter consisting of four dosage subgroups according to quartiles. Cox proportional hazard models were performed to evaluate the risk for SPCs by adjusting for variables including cumulative doses of radioactive iodine (RAI) therapy.
Results
A total of 17,410 SPC cases were observed over a median 7.3 years of follow-up. The high-dose levothyroxine subgroups (Q3 and Q4) had a higher risk for SPC (adjusted hazard ratio [HR], 1.14 and 1.27; 95% confidence interval [CI], 1.05–1.24 and 1.17– 1.37; respectively) compared to the non-levothyroxine group. In particular, the adjusted HR of stomach (1.31), colorectal (1.60), liver and biliary tract (1.95), and pancreatic (2.48) cancers were increased in the Q4 subgroup. We consistently observed a positive association between high levothyroxine dosage per body weight and risk of SPCs, even after adjusting for various confounding variables. Moreover, similar results were identified in the stratified analyses according to thyroidectomy type and RAI therapy, as well as in a subgroup analysis of patients with good adherence.
Conclusion
High-dose levothyroxine use was associated with increased risk of SPCs among thyroid cancer patients regardless of RAI therapy.

Citations

Citations to this article as recorded by  
  • The Levothyroxine Odyssey: Navigating the Path of Survivorship in Thyroid Cancer
    Jin Hwa Kim
    Endocrinology and Metabolism.2024; 39(2): 283.     CrossRef
  • Levothyroxine Dosage and the Increased Risk of Second Primary Malignancy in Thyroid Cancer Survivors
    Young Joo Park
    Clinical Thyroidology®.2024; 36(7): 258.     CrossRef
Close layer
Thyroid
Thyroid Hormone Reference Intervals among Healthy Individuals In Lanzhou, China
Yan Lu, Wen-Xia Zhang, De-Hong Li, Lian-Hua Wei, Yu-Jun Zhang, Fu-Na Shi, Shen Zhou
Endocrinol Metab. 2023;38(3):347-356.   Published online June 14, 2023
DOI: https://doi.org/10.3803/EnM.2023.1638
  • 3,485 View
  • 161 Download
  • 1 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
The common reference intervals (RIs) for thyroid hormones currently used in China are provided by equipment manufacturers. This study aimed to establish thyroid hormone RIs in the population of Lanzhou, a city in the subplateau region of northwest China, and compare them with previous reports and manufacturer-provided values.
Methods
In total, 3,123 individuals (1,680 men, 1,443 women) from Lanzhou, an iodine-adequate area of China, perceived as healthy were selected. The Abbott Architect analyzer was used to determine the serum concentration of thyroid hormones. The 95% RI was estimated using the 2.5th and 97.5th percentiles as the lower and upper reference limits, respectively.
Results
The serum levels of thyroid-stimulating hormone (TSH), total triiodothyronine (TT3), antithyroglobulin (ATG) antibody, and antithyroid peroxidase (ATPO) antibody levels were significantly correlated with sex (P<0.05). TSH, total thyroxine (TT4), and ATPO levels were significantly correlated with age (P<0.05). The serum levels of TSH, ATG, and ATPO in men were significantly lower than in women; in contrast, the serum TT3 level was significantly higher in men than in women (P<0.05). Serum TSH, TT3, TT4, and ATG levels differed across age groups (P<0.05), but no such variation was observed for ATG levels (P>0.05). The established RIs of TSH, ATG, and ATPO in this study differed between sexes (P<0.05). The thyroid hormone RIs established herein were inconsistent with the manufacturer-provided values.
Conclusion
The RIs of thyroid hormones in the healthy population of Lanzhou were inconsistent with those in the manufacturer’s manual. Validated sex-specific values are required for diagnosing thyroid diseases.

Citations

Citations to this article as recorded by  
  • Burden of non-alcoholic fatty liver disease in subclinical hypothyroidism
    Mahmood Dhahir Al-Mendalawi
    Journal of Clinical and Scientific Research.2024; 13(1): 68.     CrossRef
Close layer
Review Articles
Thyroid
Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association
A Ram Hong, Ho-Cheol Kang
Endocrinol Metab. 2023;38(2):175-189.   Published online April 27, 2023
DOI: https://doi.org/10.3803/EnM.2023.1701
  • 6,647 View
  • 322 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
Thyroid hormones play an important physiological role in maintaining adult bone structure and strength. Consequently, thyroid dysfunction is related to skeletal outcomes. Overt hyperthyroidism is an established cause of high bone turnover with accelerated bone loss, leading to osteoporosis and increased fracture risk. Hyperthyroidism induced by thyroid-stimulating hormone-suppressive therapy in patients with differentiated thyroid cancer is a cause of secondary osteoporosis. In contrast, there is a lack of evidence on the negative impact of hypothyroidism on bone health. Considering the clinical updates on the importance of bone health in thyroid dysfunction, the Task Force from the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association recently developed a position statement on the evaluation and management of bone health of patients with thyroid diseases, particularly focused on endogenous hyperthyroidism and thyroid-stimulating hormone-suppressive therapy-associated hyperthyroidism in patients with differentiated thyroid cancer. Herein, we review the Korean Thyroid Association’s position statement on the evaluation and management of bone health associated with thyroid diseases.

Citations

Citations to this article as recorded by  
  • Diagnosis and therapeutic approach to bone health in patients with hypopituitarism
    Justyna Kuliczkowska-Płaksej, Aleksandra Zdrojowy-Wełna, Aleksandra Jawiarczyk-Przybyłowska, Łukasz Gojny, Marek Bolanowski
    Reviews in Endocrine and Metabolic Disorders.2024; 25(3): 513.     CrossRef
  • Osteoporosis, Osteoarthritis, and Subchondral Insufficiency Fracture: Recent Insights
    Shunichi Yokota, Hotaka Ishizu, Takuji Miyazaki, Daisuke Takahashi, Norimasa Iwasaki, Tomohiro Shimizu
    Biomedicines.2024; 12(4): 843.     CrossRef
  • Acute hypercalcemic crisis: A narrative review with a focus on pregnancy
    Nadia Sabbah
    Annales d'Endocrinologie.2024; 85(6): 604.     CrossRef
  • Review on the protective activity of osthole against the pathogenesis of osteoporosis
    Jincai Chen, Xiaofei Liao, Juwen Gan
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Estudio comparativo tras la cirugía tiroidea y otras variables asociadas al desarrollo de osteoporosis en una cohorte latinoamericana
    María Paula Ciliberti Artavia, Juan Sebastián Theran León, Jaime Alberto Gómez Ayala, Valentina Cabrera Peña, Rafael Guillermo Parales Strauch, Edgar Camilo Blanco Pimiento, Luis Andres Dulcey Sarmiento, Juan Camilo Martínez, Juan Camilo Mayorca, María Al
    Revista Salud y Desarrollo.2023; 7(2): e605.     CrossRef
Close layer
Calcium & bone metabolism
New Insights into Calorie Restriction Induced Bone Loss
Linyi Liu, Clifford J. Rosen
Endocrinol Metab. 2023;38(2):203-213.   Published online April 27, 2023
DOI: https://doi.org/10.3803/EnM.2023.1673
  • 5,462 View
  • 211 Download
  • 7 Web of Science
  • 8 Crossref
AbstractAbstract PDFPubReader   ePub   
Caloric restriction (CR) is now a popular lifestyle choice due to its ability in experimental animals to improve lifespan, reduce body weight, and lessen oxidative stress. However, more and more emerging evidence suggests this treatment requires careful consideration because of its detrimental effects on the skeletal system. Experimental and clinical studies show that CR can suppress bone growth and raise the risk of fracture, but the specific mechanisms are poorly understood. Reduced mechanical loading has long been thought to be the primary cause of weight loss-induced bone loss from calorie restriction. Despite fat loss in peripheral depots with calorie restriction, bone marrow adipose tissue (BMAT) increases, and this may play a significant role in this pathological process. Here, we update recent advances in our understanding of the effects of CR on the skeleton, the possible pathogenic role of BMAT in CR-induced bone loss, and some strategies to mitigate any potential side effects on the skeletal system.

Citations

Citations to this article as recorded by  
  • Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity
    Jeffrey I. Mechanick, W. Scott Butsch, Sandra M. Christensen, Osama Hamdy, Zhaoping Li, Carla M. Prado, Steven B. Heymsfield
    Obesity Reviews.2025;[Epub]     CrossRef
  • Calorie restriction induces mandible bone loss by regulating mitochondrial function
    Linyi Liu, Phuong T. Le, Victoria E. DeMambro, Tiange Feng, Hanghang Liu, Wangyang Ying, Roland Baron, Clifford J. Rosen
    Bone.2025; 190: 117326.     CrossRef
  • Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by metabolic disturbances and its influence on bone health
    Gregório Corrêa Guimarães, João Bosco Costa Coelho, João Gabriel Oliveira Silva, Ana Carolina Chalfun de Sant’Ana, Cássia Alves Carrilho de Sá, Júlia Marques Moreno, Lívia Marçal Reis, Camila Souza de Oliveira Guimarães
    Osteoporosis International.2024; 35(4): 575.     CrossRef
  • Bone Marrow Adipose Tissue Is Not Required for Reconstitution of the Immune System Following Irradiation in Male Mice
    Jessica A. Keune, Carmen P. Wong, Adam J. Branscum, Scott A. Menn, Urszula T. Iwaniec, Russell T. Turner
    International Journal of Molecular Sciences.2024; 25(4): 1980.     CrossRef
  • Dietary restriction plus exercise change gene expression of Cxcl12 abundant reticular cells in female mice
    Aoi Ikedo, Yuuki Imai
    Journal of Bone and Mineral Metabolism.2024; 42(3): 271.     CrossRef
  • Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial
    Morten S. Hansen, Eva M. Wölfel, Shakespeare Jeromdesella, Jens-Jakob K. Møller, Charlotte Ejersted, Niklas R. Jørgensen, Richard Eastell, Stinus G. Hansen, Morten Frost
    eClinicalMedicine.2024; 72: 102624.     CrossRef
  • Calorie restriction in mice impairs cortical but not trabecular peak bone mass by suppressing bone remodeling
    Linyi Liu, Phuong T Le, J Patrizia Stohn, Hanghang Liu, Wangyang Ying, Roland Baron, Clifford J Rosen
    Journal of Bone and Mineral Research.2024;[Epub]     CrossRef
  • Connecting bone metastasis, adipose tissue and adipokines: How does physical activity fit?
    Paola Maroni, Marta Gomarasca, Michela Signo, Giovanni Lombardi
    Advanced Exercise and Health Science.2024; 1(3): 149.     CrossRef
Close layer
Thyroid
Thyroid Function across the Lifespan: Do Age-Related Changes Matter?
John P. Walsh
Endocrinol Metab. 2022;37(2):208-219.   Published online April 14, 2022
DOI: https://doi.org/10.3803/EnM.2022.1463
  • 9,665 View
  • 419 Download
  • 16 Web of Science
  • 20 Crossref
AbstractAbstract PDFPubReader   ePub   
Circulating concentrations of thyrotropin (TSH) and thyroxine (T4) are tightly regulated. Each individual has setpoints for TSH and free T4 which are genetically determined, and subject to environmental and epigenetic influence. Pituitary-thyroid axis setpoints are probably established in utero, with maturation of thyroid function continuing until late gestation. From neonatal life (characterized by a surge of TSH and T4 secretion) through childhood and adolescence (when free triiodothyronine levels are higher than in adults), thyroid function tests display complex, dynamic patterns which are sexually dimorphic. In later life, TSH increases with age in healthy older adults without an accompanying fall in free T4, indicating alteration in TSH setpoint. In view of this, and evidence that mild subclinical hypothyroidism in older people has no health impact, a strong case can be made for implementation of age-related TSH reference ranges in adults, as is routine in children.

Citations

Citations to this article as recorded by  
  • The ageing thyroid: implications for longevity and patient care
    Diana van Heemst
    Nature Reviews Endocrinology.2024; 20(1): 5.     CrossRef
  • Incidence and Determinants of Spontaneous Normalization of Subclinical Hypothyroidism in Older Adults
    Evie van der Spoel, Nicolien A van Vliet, Rosalinde K E Poortvliet, Robert S Du Puy, Wendy P J den Elzen, Terence J Quinn, David J Stott, Naveed Sattar, Patricia M Kearney, Manuel R Blum, Heba Alwan, Nicolas Rodondi, Tinh-Hai Collet, Rudi G J Westendorp,
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1167.     CrossRef
  • Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications
    Rosalie B. T. M. Sterenborg, Inga Steinbrenner, Yong Li, Melissa N. Bujnis, Tatsuhiko Naito, Eirini Marouli, Tessel E. Galesloot, Oladapo Babajide, Laura Andreasen, Arne Astrup, Bjørn Olav Åsvold, Stefania Bandinelli, Marian Beekman, John P. Beilby, Jette
    Nature Communications.2024;[Epub]     CrossRef
  • Evaluation of multiple organophosphate insecticide exposure in relation to altered thyroid hormones in NHANES 2007‐2008 adult population
    Massira Ousseni Diawara, Songtao Li, Mingzhi Zhang, Francis Manyori Bigambo, Xu Yang, Xu Wang, Tianyu Dong, Di Wu, Chenghao Yan, Yankai Xia
    Ecotoxicology and Environmental Safety.2024; 273: 116139.     CrossRef
  • Thyroid-function reference ranges in the diagnosis of thyroid dysfunction in adults
    Salman Razvi
    Nature Reviews Endocrinology.2024; 20(5): 253.     CrossRef
  • Association between exposure to chemical mixtures and epigenetic ageing biomarkers: Modifying effects of thyroid hormones and physical activity
    Wanying Shi, Jianlong Fang, Huimin Ren, Peijie Sun, Juan Liu, Fuchang Deng, Shuyi Zhang, Qiong Wang, Jiaonan Wang, Shilu Tong, Song Tang, Xiaoming Shi
    Journal of Hazardous Materials.2024; 469: 134009.     CrossRef
  • Biochemical pattern and prevalence of thyroid disorders among adults in a tertiary hospital in North-East Nigeria
    Bawa Ibrahim Abubkar, Longwap Abdulazis Saleh, Dauda E. Suleiman, Sanni Musa, Bosede Oluwasayo Adegoke, Ibrahim Naziru, Abbas Hamisu, Harisu Salisu, Rabi’atu Ahmad Bichi, Mansur Ramalan Aliyu, Christian Isichei
    Annals of African Medical Research.2024;[Epub]     CrossRef
  • Analysis of Inflammatory and Thyroid Hormone Levels Based on Hepatitis A and B Virus Immunity Status: Age and Sex Stratification
    Hyeokjun Yun, Jae-Sik Jeon, Jae Kyung Kim
    Viruses.2024; 16(8): 1329.     CrossRef
  • Hypothyroidism
    Peter N Taylor, Marco M Medici, Alicja Hubalewska-Dydejczyk, Kristien Boelaert
    The Lancet.2024; 404(10460): 1347.     CrossRef
  • Thyroid dysfunction among patients assessed by thyroid function tests at a tertiary care hospital: a retrospective study
    Emmanuel Donkoh Aidoo, Grace Korkor Ababio, Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, Nii Ayite Aryee
    The Pan African Medical Journal.2024;[Epub]     CrossRef
  • The relationship between serum thyroid hormone levels and symptoms severity in young children with autism
    Maria Kopcikova, Barbara Raskova, Ivan Belica, Jan Bakos, Hana Celusakova, Zuzana Chladna, Jana Zibolenova, Daniela Ostatnikova
    Endocrine Regulations.2024;[Epub]     CrossRef
  • DNA Methylation in Autoimmune Thyroid Disease
    Nicole Lafontaine, Scott G Wilson, John P Walsh
    The Journal of Clinical Endocrinology & Metabolism.2023; 108(3): 604.     CrossRef
  • A Causality between Thyroid Function and Bone Mineral Density in Childhood: Abnormal Thyrotropin May Be Another Pediatric Predictor of Bone Fragility
    Dongjin Lee, Moon Ahn
    Metabolites.2023; 13(3): 372.     CrossRef
  • Serum Lipidomic Analysis Reveals Biomarkers and Metabolic Pathways of Thyroid Dysfunction
    Hua Dong, Wenjie Zhou, Xingxu Yan, Huan Zhao, Honggang Zhao, Yan Jiao, Guijiang Sun, Yubo Li, Zuncheng Zhang
    ACS Omega.2023; 8(11): 10355.     CrossRef
  • Developmental and environmental modulation of fecal thyroid hormone levels in wild Assamese macaques (Macaca assamensis)
    Verena Behringer, Michael Heistermann, Suchinda Malaivijitnond, Oliver Schülke, Julia Ostner
    American Journal of Primatology.2023;[Epub]     CrossRef
  • Prevalence of Functional Alterations and the Effects of Thyroid Autoimmunity on the Levels of TSH in an Urban Population of Colombia: A Population-Based Study
    Hernando Vargas-Uricoechea, Valentina Agredo-Delgado, Hernando David Vargas-Sierra, María V. Pinzón-Fernández
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2023; 23(6): 857.     CrossRef
  • Genetic determinants of thyroid function in children
    Tessa A Mulder, Purdey J Campbell, Peter N Taylor, Robin P Peeters, Scott G Wilson, Marco Medici, Colin Dayan, Vincent V W Jaddoe, John P Walsh, Nicholas G Martin, Henning Tiemeier, Tim I M Korevaar
    European Journal of Endocrinology.2023; 189(2): 164.     CrossRef
  • Relationship between Thyroid CT Density, Volume, and Future TSH Elevation: A 5-Year Follow-Up Study
    Tomohiro Kikuchi, Shouhei Hanaoka, Takahiro Nakao, Yukihiro Nomura, Takeharu Yoshikawa, Md Ashraful Alam, Harushi Mori, Naoto Hayashi
    Life.2023; 13(12): 2303.     CrossRef
  • Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status
    Katleen Van Uytfanghe, Joel Ehrenkranz, David Halsall, Kelly Hoff, Tze Ping Loh, Carole A. Spencer, Josef Köhrle
    Thyroid®.2023; 33(9): 1013.     CrossRef
  • Blood hormones and suicidal behaviour: A systematic review and meta-analysis
    Xue-Lei Fu, Xia Li, Jia-Mei Ji, Hua Wu, Hong-Lin Chen
    Neuroscience & Biobehavioral Reviews.2022; 139: 104725.     CrossRef
Close layer
Diabetes, Obesity and Metabolism
Effects of Intermittent Fasting on the Circulating Levels and Circadian Rhythms of Hormones
Bo Hye Kim, Yena Joo, Min-Seon Kim, Han Kyoung Choe, Qingchun Tong, Obin Kwon
Endocrinol Metab. 2021;36(4):745-756.   Published online August 27, 2021
DOI: https://doi.org/10.3803/EnM.2021.405
  • 48,381 View
  • 1,245 Download
  • 40 Web of Science
  • 43 Crossref
AbstractAbstract PDFPubReader   ePub   
Intermittent fasting has become an increasingly popular strategy in losing weight and associated reduction in obesity-related medical complications. Overwhelming studies support metabolic improvements from intermittent fasting in blood glucose levels, cardiac and brain function, and other health benefits, in addition to weight loss. However, concerns have also been raised on side effects including muscle loss, ketosis, and electrolyte imbalance. Of particular concern, the effect of intermittent fasting on hormonal circadian rhythms has received little attention. Given the known importance of circadian hormonal changes to normal physiology, potential detrimental effects by dysregulation of hormonal changes deserve careful discussions. In this review, we describe the changes in circadian rhythms of hormones caused by intermittent fasting. We covered major hormones commonly pathophysiologically involved in clinical endocrinology, including insulin, thyroid hormones, and glucocorticoids. Given that intermittent fasting could alter both the level and frequency of hormone secretion, decisions on practicing intermittent fasting should take more considerations on potential detrimental consequences versus beneficial effects pertaining to individual health conditions.

Citations

Citations to this article as recorded by  
  • Common and divergent molecular mechanisms of fasting and ketogenic diets
    Antonio Paoli, Grant M. Tinsley, Mark P. Mattson, Immaculata De Vivo, Ravi Dhawan, Tatiana Moro
    Trends in Endocrinology & Metabolism.2024; 35(2): 125.     CrossRef
  • Identifying Acss1, Mtfp1 and Oxct1 as key regulators and promising biomarkers of sarcopenia in various models
    Hailong Cui, Die Hu, Yanling Liu, Jiejie Zhao
    Gene.2024; 896: 148053.     CrossRef
  • Circadian Rhythms, Chrononutrition, Physical Training, and Redox Homeostasis—Molecular Mechanisms in Human Health
    Cristina Manuela Drăgoi, Alina Crenguţa Nicolae, Anca Ungurianu, Denisa Marilena Margină, Daniela Grădinaru, Ion-Bogdan Dumitrescu
    Cells.2024; 13(2): 138.     CrossRef
  • Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update
    Zahra Sadat Mirrazavi, Vahideh Behrouz
    Clinical Nutrition.2024; 43(2): 519.     CrossRef
  • Attention to Innate Circadian Rhythm and the Impact of Its Disruption on Diabetes
    Da Young Lee, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Kyeong Jin Kim, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Nan Hee Kim
    Diabetes & Metabolism Journal.2024; 48(1): 37.     CrossRef
  • Genetics of Exercise and Diet-Induced Fat Loss Efficiency: A Systematic Review
    Aleksandra Bojarczuk, Emiliya S. Egorova, Magdalena Dzitkowska-Zabielska, Ildus I. Ahmetov
    Journal of Sports Science and Medicine.2024; : 236.     CrossRef
  • Ramadan fasting in the third trimester of pregnancy and postpartum colostrum cortisol concentrations in Morocco
    Meagan M. Guilfoyle
    American Journal of Human Biology.2024;[Epub]     CrossRef
  • Intermittent fasting as a dietary intervention with potential sexually dimorphic health benefits
    Julia Rius-Bonet, Salvador Macip, Daniel Closa, Marta Massip-Salcedo
    Nutrition Reviews.2024;[Epub]     CrossRef
  • Dietary factors in circadian rhythm modulation and their impact on metabolic diseases: a state of the science review
    Malvika Dalvi, Srujana Medithi
    Biological Rhythm Research.2024; 55(3-4): 233.     CrossRef
  • Unlocking the Benefits of Fasting: A Review of its Impact on Various Biological Systems and Human Health
    Rawan Mackieh, Nadia Al-Bakkar, Milena Kfoury, Nathalie Okdeh, Hervé Pietra, Rabih Roufayel, Christian Legros, Ziad Fajloun, Jean-Marc Sabatier
    Current Medicinal Chemistry.2024; 31(14): 1781.     CrossRef
  • Chrono-Endocrinology in Clinical Practice: A Journey from Pathophysiological to Therapeutic Aspects
    Silvia Mercadante, Antonio Bellastella
    Life.2024; 14(5): 546.     CrossRef
  • Pu‐erh tea reduces the transmission of CRD‐mediated alopecia risk to offspring
    Shanshan Hu, Jie Wang, Zhiyuan Lin, Bowen Zhang, Liyong Luo, Liang Zeng
    Food Frontiers.2024; 5(4): 1673.     CrossRef
  • Effects of Early and Late Time-Restricted Feeding on Parameters of Metabolic Health: An Explorative Literature Assessment
    Froso Petridi, Jan M. W. Geurts, Jean Nyakayiru, Anne Schaafsma, Dedmer Schaafsma, Ruth C. R. Meex, Cécile M. Singh-Povel
    Nutrients.2024; 16(11): 1721.     CrossRef
  • Ramadan intermittent fasting is associated with improved anticoagulant activity among healthy people: a case–control study
    Abeer Khalid Al-Ghumlas
    Scientific Reports.2024;[Epub]     CrossRef
  • Adaptive Effects of Endocrine Hormones on Metabolism of Macronutrients during Fasting and Starvation: A Scoping Review
    Reza Karimi, Alina Yanovich, Fawzy Elbarbry, Anita Cleven
    Metabolites.2024; 14(6): 336.     CrossRef
  • The effect of intermittent fasting on preventing obesity-related early aging from a molecular and cellular perspective
    Nurma Yuliyanasari, Purwo Sri Rejeki, Hanik Badriyah Hidayati, Phawinee Subsomwong, Muhammad Miftahussurur
    Journal of Medicine and Life.2024; 17(3): 261.     CrossRef
  • Marital Status and Serum Level of Testosterone: In Relation to Serum Level of Cortisol
    Rezanezhad Babak, Borgquist Rasmus, Elzanaty Saad
    Archive of Urological Research.2024; 8(2): 018.     CrossRef
  • Evaluating the efficacy of intermittent fasting and exercise combinations for weight loss: A network meta‐analysis
    Xiaoyan Cheng, Shunli Sun, Maolin Chen, Xinyou Zhou, Mingxin Rao, Dongjuan Guo, Jinfeng Xie, Qiang Huang, Liqiang Su
    Obesity Reviews.2024;[Epub]     CrossRef
  • Effects of Intermittent Fasting on Female Reproductive Function: A Review of Animal and Human Studies
    Lei Mao, Aixia Liu, Xiaohui Zhang
    Current Nutrition Reports.2024; 13(4): 786.     CrossRef
  • Impact of Modern Lifestyle on Circadian Health and Its Contribution to Adipogenesis and Cancer Risk
    Oxana Dobrovinskaya, Javier Alamilla, Miguel Olivas-Aguirre
    Cancers.2024; 16(21): 3706.     CrossRef
  • Religious intermittent fasting: Effects on liver health, metabolic markers, and gut microbiota in type 2 diabetes patients
    Svenja Sydor, Ender Engin, Samantha Wittek, Peter Lemmer, Jan Best, Martin Steinmetz, Anja Figge, Andreas Jähnert, Mustafa Özcürümez, Martina Broecker-Preuss, Wing-Kin Syn, Ali Canbay, Paul Manka
    Clinical Nutrition Open Science.2024; 58: 370.     CrossRef
  • Intermittent fasting: Effectiveness and safety. A review
    Marina V. Altashina, Ekaterina V. Ivannikova, Ekaterina A. Troshina
    Terapevticheskii arkhiv.2024; 96(10): 984.     CrossRef
  • Examining Associations Between Fasting Behavior, Orthorexia Nervosa, and Eating Disorders
    Przemysław Domaszewski, Aleksandra M. Rogowska, Kaja Żylak
    Nutrients.2024; 16(24): 4275.     CrossRef
  • Fasting intervention and its clinical effects on the human host and microbiome
    Sofia K. Forslund
    Journal of Internal Medicine.2023; 293(2): 166.     CrossRef
  • Umbrella review of time-restricted eating on weight loss, fasting blood glucose, and lipid profile
    Han Shi Jocelyn Chew, Wei How Darryl Ang, Zhen Yang Abel Tan, Wen Wei Ang, Kin Sun Chan, Ying Lau
    Nutrition Reviews.2023; 81(9): 1180.     CrossRef
  • Thermodynamic Assessment of the Effects of Intermittent Fasting and Fatty Liver Disease Diets on Longevity
    Melek Ece Öngel, Cennet Yildiz, Özge Başer, Bayram Yilmaz, Mustafa Özilgen
    Entropy.2023; 25(2): 227.     CrossRef
  • Effects of Intermittent Fasting on Hypothalamus–Pituitary–Thyroid Axis, Palatable Food Intake, and Body Weight in Stressed Rats
    Cinthia García-Luna, Ixchel Prieto, Paulina Soberanes-Chávez, Elena Alvarez-Salas, Iván Torre-Villalvazo, Gilberto Matamoros-Trejo, Patricia de Gortari
    Nutrients.2023; 15(5): 1164.     CrossRef
  • Possible homeostatic, glucose uptake mechanisms and hepato-pancreatic histological effects of intermittent fasting, exercise, starvation, and honey in streptozotocin-induced diabetes in rats
    Ejime A. Chijiokwu, Eze K. Nwangwa, Mega O. Oyovwi, Benneth Ben-Azu, Alexander O. Naiho, Emuesiri Goodies Moke, Victor Emojevwe, Prosper A. Ehiwarior, Udoka S. Nwabuoku
    Nutrire.2023;[Epub]     CrossRef
  • Mid-Point of the Active Phase Is Better to Achieve the Natriuretic Effect of Acute Salt Load in Mice
    Momoko Imamura, Hiroyuki Sasaki, Katsuki Hayashi, Shigenobu Shibata
    Nutrients.2023; 15(7): 1679.     CrossRef
  • All That Glitters Is Not Gold: The Same Sleep Time, but Different Diabetogenic Outcomes
    Bohye Kim, Obin Kwon
    Endocrinology and Metabolism.2023; 38(1): 78.     CrossRef
  • The emerging role of circadian rhythms in the development and function of thermogenic fat
    Xuemin Peng, Yong Chen
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Time-restricted Feeding Changes as Inspiration for Drug Design
    Zhangyuting He, Huayu Yang, Yilei Mao
    Current Pharmaceutical Design.2023; 29(8): 559.     CrossRef
  • Brain Dopamine–Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects
    Anthony H. Cincotta
    International Journal of Molecular Sciences.2023; 24(17): 13255.     CrossRef
  • Adaptive Circadian Rhythms for Autonomous and Biologically Inspired Robot Behavior
    Marcos Maroto-Gómez, María Malfaz, Álvaro Castro-González, Sara Carrasco-Martínez, Miguel Ángel Salichs
    Biomimetics.2023; 8(5): 413.     CrossRef
  • Intermittent Fasting on Human Health and Disease
    Denisa Marilena Margină, Cristina Manuela Drăgoi
    Nutrients.2023; 15(21): 4491.     CrossRef
  • Synthetic augmentation of bilirubin metabolism in human pluripotent stem cell-derived liver organoids
    Hasan Al Reza, Zishaan Farooqui, Abid Al Reza, Callen Conroy, Kentaro Iwasawa, Yasuhiro Ogura, Keisuke Okita, Kenji Osafune, Takanori Takebe
    Stem Cell Reports.2023; 18(11): 2071.     CrossRef
  • Average phenotype but not plasticity in two metabolic hormones covary in wild female bonobos (Pan paniscus)
    Ruth Sonnweber, Gottfried Hohmann, Jeroen M. G. Stevens, Tobias Deschner, Barbara Fruth, Anna-Lena Fiedler, Niina O. Nurmi, Verena Behringer
    Frontiers in Ecology and Evolution.2023;[Epub]     CrossRef
  • Intermittent fasting, high-intensity interval training, or a combination of both have beneficial effects in obese mice with nonalcoholic fatty liver disease
    Patrícia de Castro-de-Paiva, Thatiany de Souza Marinho, Carlos Alberto Mandarim-de-Lacerda, Marcia Barbosa Aguila
    The Journal of Nutritional Biochemistry.2022; 104: 108997.     CrossRef
  • Optimal Timing of Thyroid Hormone Replacement During Ramadan Fasting: A Randomized Controlled Trial in Patients with Prior Total Thyroidectomy
    Khalid M. Al-Qahtani, Ibraheem Ahmed Aldeeri, Amal M. Alshaibi, Norah Salman Alshabib, Rakan M. Barghouthi, Ebtihal Y. Alyusuf, Anwar Ali Jammah
    Thyroid.2022; 32(9): 1029.     CrossRef
  • Exploring the Effects of Energy Constraints on Performance, Body Composition, Endocrinological/Hematological Biomarkers, and Immune System among Athletes: An Overview of the Fasting State
    Hadi Nobari, Saber Saedmocheshi, Eugenia Murawska-Ciałowicz, Filipe Manuel Clemente, Katsuhiko Suzuki, Ana Filipa Silva
    Nutrients.2022; 14(15): 3197.     CrossRef
  • Alternate day fasting and time-restricted feeding may confer similar neuroprotective effects during aging in male rats
    Sukanya Bhoumik, Rashmi Kesherwani, Raushan Kumar, Syed Ibrahim Rizvi
    Biogerontology.2022; 23(6): 757.     CrossRef
  • Intermittent Fasting—A Healthy Dietary Pattern for Diabetic Nephropathy
    Ming Yang, Wei Chen, Liyu He, Di Liu, Li Zhao, Xi Wang
    Nutrients.2022; 14(19): 3995.     CrossRef
  • β-hydroxybutyrate as an Anti-Aging Metabolite
    Lian Wang, Peijie Chen, Weihua Xiao
    Nutrients.2021; 13(10): 3420.     CrossRef
Close layer
Original Article
Thyroid
Thyroid Hormone Profile and Its Prognostic Impact on the Coronavirus Disease 2019 in Korean Patients
Jiyeon Ahn, Min Kyung Lee, Jae Hyuk Lee, Seo Young Sohn
Endocrinol Metab. 2021;36(4):769-777.   Published online August 27, 2021
DOI: https://doi.org/10.3803/EnM.2021.1109
  • 5,589 View
  • 192 Download
  • 21 Web of Science
  • 22 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Data on the association between coronavirus disease 2019 (COVID-19) and thyroid have been reported, including overt thyrotoxicosis and suppression of thyroid function. We aimed to evaluate the thyroid hormone profile and its association with the prognosis of COVID-19 in Korean patients.
Methods
The clinical data of 119 patients with COVID-19, admitted in the Myongji Hospital, Goyang, South Korea, were retrospectively evaluated. The thyroid hormone profiles were analyzed and compared based on disease severity (non-severe disease vs. severe to critical disease). Clinical outcomes were analyzed according to the tertiles of thyroid hormones.
Results
Of the 119 patients, 76 (63.9%) were euthyroid, and none presented with overt thyroid dysfunction. Non-thyroidal illness syndrome was the most common manifestation (18.5%), followed by subclinical thyrotoxicosis (14.3%) among patients with thyroid dysfunction. Thyroid stimulating hormone (TSH) and triiodothyronine (T3) levels were significantly lower in patients with severe to critical disease than in those with non-severe disease (P<0.05). Patients in the lowest T3 tertile (<0.77 ng/mL) had higher rates of mechanical ventilation, intensive care unit admission, and death than those in the middle and highest (>1.00 ng/mL) T3 tertiles (P<0.05). COVID-19 patients in the lowest T3 tertile were independently associated with mortality (hazard ratio, 5.27; 95% confidence interval, 1.09 to 25.32; P=0.038) compared with those in the highest T3 tertile.
Conclusion
Thyroid dysfunction is common in COVID-19 patients. Changes in serum TSH and T3 levels may be important markers of disease severity in COVID-19. Decreased T3 levels may have a prognostic significance in COVID-19 related outcome.

Citations

Citations to this article as recorded by  
  • The prevalence of thyroid disorders in COVID-19 patients: a systematic review and meta-analysis
    Sadra Ashrafi, Hossein Hatami, Razieh Bidhendi-Yarandi, Mohammad Hossein Panahi
    BMC Endocrine Disorders.2024;[Epub]     CrossRef
  • Thyroid Stimulating Hormone as a Possible Additional COVID-19 Outcome Marker
    Anamarija Zrilic Vrkljan, Ana Majic Tengg, Tanja Palaversa, Srecko Marusic, Lana Ruzic, Ines Bilic-Curcic, Maja Cigrovski Berkovic
    Medicina.2024; 60(2): 314.     CrossRef
  • Effect of Hypothalamic Adrenal Axis and Thyroid Function Alterations on Prognosis of Critically Ill COVID-19 Patients
    Muhammet KORKUSUZ, Sulbiye KARABURGU, Tayfun ET, Rafet YARIMOĞLU, Nuh KUMRU
    Namık Kemal Tıp Dergisi.2024; 12(1): 17.     CrossRef
  • Patterns of thyroid gland dysfunction among hospitalized patients with COVID-19 pneumonia
    Fatima Al Taher Taha Morsi, Marwan Elgohary, Ahmed A. Abdelmoaty, Maha E. Alsadik, Samah M. Shehata, Mohamed Ahmed EL Maghawry
    The Egyptian Journal of Bronchology.2024;[Epub]     CrossRef
  • Association between thyroid function and prognosis of severe COVID-19 among patients with SARS-CoV-2 infection: a retrospective cohort study in China
    Yaling Yang, Lifang Qian, Chenwei Wu, Xinyue Xu, Duoduo Qu, Lihua Zhou, Jia Liu, Qin Zhu, Chunhong Wang, Xiaolong Zhao
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Thyroid Function in the Time of COVID-19: A Systematic Review of Disease Progression and Vaccination Effect
    Maryam Zarkesh, Maryam Sanoie, Shabnam Heydarzadeh, Raziyeh Abooshahab, Afsoon Daneshafrooz, Farhad Hosseinpanah, Mehdi Hedayati
    International Journal of Endocrinology and Metabolism.2024;[Epub]     CrossRef
  • Thyroxine changes in COVID-19 pandemic: A systematic review and meta-analysis
    Ziqi Li, Pengwei Hou, Shuwen Mu, Renzhi Wang, Hui Miao, Ming Feng, He Wang, Wentai Zhang, Yihao Chen, Tianshun Feng, Shousen Wang, Yi Fang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The Influence of SARS-CoV-2 Infection on the Thyroid Gland
    Aleksandra Piekarska, Marta Góral, Marta Kozula, Aleksandra Jawiarczyk-Przybyłowska, Katarzyna Zawadzka, Marek Bolanowski
    Biomedicines.2023; 11(2): 614.     CrossRef
  • Thyroid Function Abnormalities and Outcomes in Hospitalized Patients with COVID-19 Infection: A Cross-Sectional Study
    Deepika Patel, Dukhabandhu Naik, Sadishkumar Kamalanathan, Kadhiravan Tamilarasu, Jayaprakash Sahoo, Ayan Roy, Chandhana Merugu, Varun Suryadevara
    Hormone and Metabolic Research.2023; 55(03): 169.     CrossRef
  • The Spectrum of Thyroid Function Tests and Autoantibodies During Hospitalization and After Six Months of Discharge in COVID-19 Patients: Does COVID-19 Trigger Autoimmunity?
    Ziynet Alphan Uc, Pinar Yagcı, Zelal Adibelli, Cevdet Duran
    Endocrine Research.2023; 48(2-3): 44.     CrossRef
  • Transient low T3 syndrome in patients with COVID-19: a new window for prediction of disease severity
    Mingyao Zhong, Yue Gao, Hongling Hu, Xuan Zhu, Lulu Gan, Ling Li, Cheng Xiang, Yimin Yan, Zhe Dai
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Affectation of the thyroid gland post SARS-CoV-2
    João Pedro Souto Silva, Erico Gerardo Laube
    SCT Proceedings in Interdisciplinary Insights and Innovations.2023; 1: 171.     CrossRef
  • The Association Between COVID-19 and Thyroxine Levels: A Meta-Analysis
    Yiru Chen, Xiuneng Li, Yu Dai, Jingjing Zhang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine
    Mihaela Popescu, Adina Ghemigian, Corina Maria Vasile, Andrei Costache, Mara Carsote, Alice Elena Ghenea
    Diagnostics.2022; 12(4): 960.     CrossRef
  • Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19
    Stephani C. Wang, Fengmin Zhang, Hui Zhu, Haipeng Yang, Yang Liu, Ping Wang, Vladimir Parpura, Yu-Feng Wang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The Association Between FT3 With the Outcome and Inflammation/Coagulopathy/Fibrinolysis of COVID-19
    Jiayi Deng, Siye Zhang, Fei Peng, Quan Zhang, Yi Li, Yanjun Zhong
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Primary hypothyroidism with an episode of ventricular tachycardia in a patient with COVID-19
    Pin-Hsu Liao, Yu-Cheng Cheng, Po-Yu Liu, I-Te Lee
    Medicine.2022; 101(25): e29243.     CrossRef
  • Low triiodothyronine syndrome is associated with stroke‐associated pneumonia
    Huijun Chen, Minjie Xu, Yezhi Huang, Jincai He, Wenwei Ren
    European Journal of Clinical Investigation.2022;[Epub]     CrossRef
  • Association of thyroid dysfunction and COVID-19: A systematic review and meta-analysis
    Mohammad Darvishi, Mohammad Reza Nazer, Hamze Shahali, Majid Nouri
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The prognostic utility of serum thyrotropin in hospitalized Covid-19 patients: statistical and machine learning approaches
    E. Pappa, P. Gourna, G. Galatas, M. Manti, A. Romiou, L. Panagiotou, R. Chatzikyriakou, N. Trakas, G. Feretzakis, C. Christopoulos
    Endocrine.2022; 80(1): 86.     CrossRef
  • Thyrotropin Levels in Patients with Coronavirus Disease 2019: Assessment during Hospitalization and in the Medium Term after Discharge
    Abdallah Al-Salameh, Noémie Scherman, Imane Adda, Juliette André, Yoann Zerbib, Julien Maizel, Jean-Daniel Lalau, Etienne Brochot, Claire Andrejak, Rachel Desailloud
    Life.2022; 12(12): 2014.     CrossRef
  • COVID-19 and thyroid function: What do we know so far?
    Camila Lüdke Rossetti, Juliana Cazarin, Fabio Hecht, Fabyan Esberard de Lima Beltrão, Andrea Cláudia Freitas Ferreira, Rodrigo Soares Fortunato, Helton Estrela Ramos, Denise Pires de Carvalho
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
Close layer
Review Articles
Thyroid
The Role of Thyroid Hormone in the Regulation of Cerebellar Development
Sumiyasu Ishii, Izuki Amano, Noriyuki Koibuchi
Endocrinol Metab. 2021;36(4):703-716.   Published online August 9, 2021
DOI: https://doi.org/10.3803/EnM.2021.1150
  • 5,596 View
  • 186 Download
  • 13 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   ePub   
The proper organized expression of specific genes in time and space is responsible for the organogenesis of the central nervous system including the cerebellum. The epigenetic regulation of gene expression is tightly regulated by an intrinsic intracellular genetic program, local stimuli such as synaptic inputs and trophic factors, and peripheral stimuli from outside of the brain including hormones. Some hormone receptors are expressed in the cerebellum. Thyroid hormones (THs), among numerous circulating hormones, are well-known major regulators of cerebellar development. In both rodents and human, hypothyroidism during the postnatal developmental period results in abnormal morphogenesis or altered function. THs bind to the thyroid hormone receptors (TRs) in the nuclei and with the help of transcriptional cofactors regulate the transcription of target genes. Gene regulation by TR induces cell proliferation, migration, and differentiation, which are necessary for brain development and plasticity. Thus, the lack of TH action mediators may directly cause aberrant cerebellar development. Various kinds of animal models have been established in a bid to study the mechanism of TH action in the cerebellum. Interestingly, the phenotypes differ greatly depending on the models. Herein we summarize the actions of TH and TR particularly in the developing cerebellum.

Citations

Citations to this article as recorded by  
  • Neuropeptides and Their Roles in the Cerebellum
    Zi-Hao Li, Bin Li, Xiao-Yang Zhang, Jing-Ning Zhu
    International Journal of Molecular Sciences.2024; 25(4): 2332.     CrossRef
  • Mapping Thyroid Hormone Action in the Human Brain
    Federico Salas-Lucia
    Thyroid®.2024; 34(7): 815.     CrossRef
  • Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells
    Yijun Yang, Silvia Anahi Valdés-Rives, Qing Liu, Tong Gao, Chakkapong Burudpakdee, Yuzhe Li, Jun Tan, Yinfei Tan, Christian A. Koch, Yuan Rong, Steven R. Houser, Shuanzeng Wei, Kathy Q. Cai, Jinhua Wu, Sheue-yann Cheng, Robert Wechsler-Reya, Zeng-jie Yang
    Cancer Cell.2024; 42(8): 1434.     CrossRef
  • The Effects of Thyroid Hormones on Brain Development
    Izuki Amano
    The Kitakanto Medical Journal.2024; 74(3): 213.     CrossRef
  • Exploring the underlying molecular mechanism of tri(1,3-dichloropropyl) phosphate-induced neurodevelopmental toxicity via thyroid hormone disruption in zebrafish by multi-omics analysis
    Ying Xu, Lei Yang, Yanguo Teng, Jian Li, Na Li
    Aquatic Toxicology.2023; 258: 106510.     CrossRef
  • Association of Maternal TSH, FT4 With Children's BMI Trajectories, and Obesity: A Birth Cohort Study
    Mengting Yang, Shanshan Zhang, Yuzhu Teng, Xue Ru, Linlin Zhu, Yan Han, Xingyong Tao, Hui Cao, Shuangqin Yan, Fangbiao Tao, Kun Huang
    The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e190.     CrossRef
  • Thyroid hormone receptor beta: Relevance in human health and diseases
    Ghausiya Rehman, Neha Kumari, Farhad Bano, Rakesh K. Tyagi
    Endocrine and Metabolic Science.2023; 13: 100144.     CrossRef
  • Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases
    Qianyu Tang, Min Zeng, Linxi Chen, Nian Fu
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Histone Deacetylase 3 Inhibitor Alleviates Cerebellar Defects in Perinatal Hypothyroid Mice by Stimulating Histone Acetylation and Transcription at Thyroid Hormone-Responsive Gene Loci
    Alvin Susetyo, Sumiyasu Ishii, Yuki Fujiwara, Izuki Amano, Noriyuki Koibuchi
    International Journal of Molecular Sciences.2022; 23(14): 7869.     CrossRef
  • Selection-driven adaptation to the extreme Antarctic environment in the Emperor penguin
    Federica Pirri, Lino Ometto, Silvia Fuselli, Flávia A. N. Fernandes, Lorena Ancona, Nunzio Perta, Daniele Di Marino, Céline Le Bohec, Lorenzo Zane, Emiliano Trucchi
    Heredity.2022; 129(6): 317.     CrossRef
  • Long-term depression–inductive stimulation causes long-term potentiation in mouse Purkinje cells with a mutant thyroid hormone receptor
    Ayane Ninomiya, Izuki Amano, Michifumi Kokubo, Yusuke Takatsuru, Sumiyasu Ishii, Hirokazu Hirai, Nobutake Hosoi, Noriyuki Koibuchi
    Proceedings of the National Academy of Sciences.2022;[Epub]     CrossRef
Close layer
Bone Metabolism
Normocalcemic Primary Hyperparathyroidism: Need for a Standardized Clinical Approach
Guido Zavatta, Bart L. Clarke
Endocrinol Metab. 2021;36(3):525-535.   Published online June 1, 2021
DOI: https://doi.org/10.3803/EnM.2021.1061
  • 8,912 View
  • 485 Download
  • 14 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   ePub   
Since normocalcemic primary hyperparathyroidism (NHPT) was first defined at the Third International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism in 2008, many papers have been published describing its prevalence and possible complications. Guidelines for the management of this condition are still lacking, and making the diagnosis requires fulfillment of strict criteria. Recent studies have shown that intermittent oscillations of serum calcium just below and slightly above the normal limits are very frequent, therefore challenging the assumption that serum calcium must be consistently normal to make the diagnosis. There is debate if these variations in serum calcium outside the normal range should be included under the rubric of NHPT or, rather, a milder form of classical primary hyperparathyroidism. Innovative approaches to define NHPT have been proposed that still need to be validated in prospective studies. Non-classical complications, especially cardiovascular complications, have been associated with NHPT, indicating that hyperparathyroidism may be a cardiovascular risk factor. New associations between parathyroid hormone (PTH) and several other comorbidities have also been reported from observational studies, suggesting that excessive PTH secretion might cause tissue dysfunction independent of serum calcium. Heterogeneous studies using different definitions of NHPT, however, make it difficult to draw definitive conclusions regarding the role of PTH excess when complications other than osteoporosis or kidney stones are described. This review will focus on clinical aspects and suggest an approach to NHPT.

Citations

Citations to this article as recorded by  
  • Surgery for Normocalcemic Hyperparathyroidism
    Pallavi Kulkarni, David Goldenberg
    Otolaryngologic Clinics of North America.2024; 57(1): 111.     CrossRef
  • Linea guida sulla gestione terapeutica dell’iperparatiroidismo primario sporadico nell’adulto
    Fabio Vescini, Marco Boniardi, Marina Carotti, Elena Castellano, Cristiana Cipriani, Cristina Eller-Vainicher, Sandro Giannini, Maurizio Iacobone, Francesca Pace, Antonio Stefano Salcuni, Federica Saponaro, Stefano Spiezia, Annibale Versari, Guido Zavatta
    L'Endocrinologo.2024; 25(2): 222.     CrossRef
  • Evaluation of the Thiazide Challenge Test to Differentiate Primary From Hypercalciuria-Related Hyperparathyroidism
    Ewout Verly, Bruno Lapauw, Charlotte Verroken
    The Journal of Clinical Endocrinology & Metabolism.2024;[Epub]     CrossRef
  • Secular trends in the incidence and treatment patterns of primary hyperparathyroidism in Korea: a nationwide cohort study
    Kyoung Jin Kim, Seungjin Baek, Min Heui Yu, Sungjae Shin, Sungjoon Cho, Yumie Rhee, Namki Hong
    JBMR Plus.2024;[Epub]     CrossRef
  • Primary hyperparathyroidism: from guidelines to outpatient clinic
    Andrea Palermo, Gaia Tabacco, Polyzois Makras, Guido Zavatta, Pierpaolo Trimboli, Elena Castellano, Maria P. Yavropoulou, Anda Mihaela Naciu, Athanasios D. Anastasilakis
    Reviews in Endocrine and Metabolic Disorders.2024; 25(5): 875.     CrossRef
  • Primary hyperparathyroidism caused by an ectopic parathyroid adenoma in the mediastinum (case report)
    Y. B. Topolnitskiy, T. A. Milovanova, D. G. Apalkov, Е. Е. Bibik, A. I. Goncharova, M. O. Tsvetukhin
    Endocrine Surgery.2024; 18(3): 36.     CrossRef
  • DXA-based bone strain index in normocalcemic primary hyperparathyroidism
    Gaia Tabacco, Anda Mihaela Naciu, Carmelo Messina, Gianfranco Sanson, Luca Rinaudo, Roberto Cesareo, Stefania Falcone, Nicola Napoli, Fabio Massimo Ulivieri, Andrea Palermo
    Osteoporosis International.2023; 34(5): 999.     CrossRef
  • Iperparatiroidismo primario normocalcemico
    Silvia Egiddi, Luigi Bonifazi Meffe, Anda Mihaela Naciu, Gaia Tabacco, Nicola Napoli, Andrea Palermo
    L'Endocrinologo.2023; 24(3): 249.     CrossRef
  • The Russian registry of primary hyperparathyroidism, latest update
    Natalia G. Mokrysheva, Anna K. Eremkina, Alina R. Elfimova, Elena V. Kovaleva, Anastasiia P. Miliutina, Ekaterina E. Bibik, Anna M. Gorbacheva, Ekaterina A. Dobreva, Irina S. Maganeva, Julia A. Krupinova, Rustam H. Salimkhanov, Lizaveta A. Aboishava, Elen
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Incidental Normocalcemic Primary Hyperparathyroidism Presenting With Symptomatic Hypophosphatemia: A Case Report
    Omar Tabbikha, Joanne Chamy, Michael El Khoury
    Cureus.2023;[Epub]     CrossRef
  • Long-term effects of hypercalcemia in kidney transplant recipients with persistent hyperparathyroidism
    Juan Carlos Ramirez-Sandoval, Lluvia Marino, Gabriel Cojuc-Konigsberg, Estefania Reul-Linares, Nathalie Desire Pichardo-Cabrera, Cristino Cruz, Elisa Naomi Hernández-Paredes, Nathan Berman-Parks, Vanessa Vidal-Ruíz, Jonathan Mauricio Estrada-Linares, Alfr
    Journal of Nephrology.2023; 37(6): 1497.     CrossRef
  • Evaluating Patients for Secondary Causes of Osteoporosis
    E. Michael Lewiecki
    Current Osteoporosis Reports.2022; 20(1): 1.     CrossRef
  • Preoperative Thoracic Muscle Mass Predicts Bone Density Change After Parathyroidectomy in Primary Hyperparathyroidism
    Seung Won Burm, Namki Hong, Seunghyun Lee, Gi Jeong Kim, Sang Hyun Hwang, Jongju Jeong, Yumie Rhee
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(6): e2474.     CrossRef
  • Applications of Metabolomics in Calcium Metabolism Disorders in Humans
    Beata Podgórska, Marta Wielogórska-Partyka, Joanna Godzień, Julia Siemińska, Michał Ciborowski, Małgorzata Szelachowska, Adam Krętowski, Katarzyna Siewko
    International Journal of Molecular Sciences.2022; 23(18): 10407.     CrossRef
  • Serum Calcium/Phosphorus Ratio in Biochemical Screening of Primary Hyperparathyroidism
    Nagihan Bestepe, Fatma Neslihan Cuhaci, Burcak Polat, Berna Evranos Ogmen, Didem Ozdemir, Reyhan Ersoy, Bekir Cakir
    Revista da Associação Médica Brasileira.2022; 68(12): 1668.     CrossRef
Close layer
Original Article
Clinical Study
Radioactive Parathyroid Adenomas on Sestamibi Scans: Low Parathyroid Hormone Secretory Potential and Large Volume
Sung Hye Kong, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin
Endocrinol Metab. 2021;36(2):351-358.   Published online April 6, 2021
DOI: https://doi.org/10.3803/EnM.2020.823
  • 4,117 View
  • 134 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
We investigated the clinical characteristics of parathyroid adenomas according to radioactivity on 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) single-photon emission computed tomography/computed tomography (SPECT/CT) in primary hyperparathyroidism (PHPT) patients.
Methods
The study included 217 patients diagnosed with PHPT from 2000 to 2019 at Seoul National University Hospital who underwent 99mTc-MIBI SPECT/CT scans. On SPECT/CT, the radioactivity of parathyroid adenomas was measured as the ratio of the mean radioactivity count of the parathyroid adenoma to that of the contralateral thyroid.
Results
Tumors were localized by MIBI scans in 190 patients (MIBI [+] group) and by ultrasound or parathyroid four-dimensional CT in 27 patients (MIBI [–] group). The mean age was 55 years, and mean body mass index was 23.4 kg/m2. Patients in the MIBI (+) group had higher parathyroid hormone (iPTH) and lower 25-hydroxy vitamin D levels than those in the MIBI (–) group (168.0 pg/mL [interquartile range, IQR, 111.0 to 250.7] vs. 134.7 pg/mL [IQR, 98.2 to 191.2], P=0.049; 15.4 ng/mL [IQR, 11.1 to 20.8] vs. 21.2 ng/mL [IQR, 13.9 to 24.8], P=0.012, respectively). Patients in the MIBI (+) group had larger tumor volumes, but lower iPTH/volume ratios than those in the MIBI (–) group (1,216.66 [IQR, 513.40 to 2,663.02], 499.82 mm3 [IQR, 167.77 to 1,229.80], P=0.002; 0.18 [IQR, 0.08 to 0.46], 0.40 pg/mL/mm3 [IQR, 0.16 to 1.29], P=0.016, respectively). Adenoma radioactivity was positively correlated with calcium, iPTH, and volume (r=0.180, P=0.020; r=0.208, P=0.006; r=0.288, P<0.001, respectively), but not with iPTH/volume.
Conclusion
Parathyroid adenomas with positive MIBI scans had larger volumes and higher iPTH than adenomas with negative scans, but lower iPTH per unit volume.

Citations

Citations to this article as recorded by  
  • Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality
    Sung Hye Kong, Jeong Mo Bae, Jung Hee Kim, Sang Wan Kim, Dohyun Han, Chan Soo Shin
    Endocrinology and Metabolism.2024; 39(2): 375.     CrossRef
  • Incidentally detected follicular thyroid carcinoma mimicking parathyroid adenoma on Tc-99m MIBI scan: A case report
    Yeon-Hee Han, Hwan-Jeong Jeong, Sun Young Lee, Seok Tae Lim
    Medicine.2024; 103(18): e38107.     CrossRef
  • Atypical parathyroid tumor: clinical and parathyroid hormone response to surgical treatment
    Antonio Giulio Napolitano, Massimo Monacelli, Valeria Liparulo, Eleonora Coviello, Domenico Pourmolkara, Stefano Avenia, Andrea Polistena
    Annals of Surgical Treatment and Research.2023; 105(2): 76.     CrossRef
  • The Relationship between Planar and SPECT/CT Parameters and Functional Markers in Primary Hyperparathyroidism
    Guler Silov, Serpil Erdogan Ozbodur
    Diagnostics.2023; 13(20): 3182.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP